| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PT Kalbe Farma Tbk (JK: KLBF)
KLBF Technical Analysis
4
| As on 24th Nov 2025 KLBF STOCK Price closed @ 1170.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1296.33 & Strong Sell for SHORT-TERM with Stoploss of 1322.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KLBFSTOCK Price
| Open | 1200.00 | Change | Price | % |
| High | 1220.00 | 1 Day | -40.00 | -3.31 |
| Low | 1170.00 | 1 Week | -115.00 | -8.95 |
| Close | 1170.00 | 1 Month | 85.00 | 7.83 |
| Volume | 1980522600 | 1 Year | -325.00 | -21.74 |
| 52 Week High 1600.00 | 52 Week Low 1020.00 | ||||
JK Indonesia Most Active Stocks
| BUMI | 218.00 | -0.91% |
| KLBF | 1170.00 | -3.31% |
| BWPT | 164.00 | 10.07% |
| BULL | 306.00 | 4.08% |
| BIPI | 92.00 | 1.10% |
| MINA | 238.00 | 5.31% |
| ENRG | 1015.00 | 9.14% |
| MPOW | 136.00 | 12.40% |
| DEWA | 416.00 | 0.00% |
| BRMS | 1025.00 | 3.54% |
JK Indonesia Top Gainers Stocks
JK Indonesia Top Losers Stocks
| KLBF Daily Charts |
KLBF Intraday Charts |
Whats New @ Bazaartrend |
KLBF Free Analysis |
|
|
KLBF Important Levels Intraday
| RESISTANCE | 1266.35 |
| RESISTANCE | 1235.45 |
| RESISTANCE | 1216.35 |
| RESISTANCE | 1197.25 |
| SUPPORT | 1142.75 |
| SUPPORT | 1123.65 |
| SUPPORT | 1104.55 |
| SUPPORT | 1073.65 |
KLBF Forecast November 2025
| 4th UP Forecast | 1449.42 |
| 3rd UP Forecast | 1359.81 |
| 2nd UP Forecast | 1304.42 |
| 1st UP Forecast | 1249.03 |
| 1st DOWN Forecast | 1090.98 |
| 2nd DOWN Forecast | 1035.59 |
| 3rd DOWN Forecast | 980.2 |
| 4th DOWN Forecast | 890.59 |
KLBF Weekly Forecast
| 4th UP Forecast | 1275.99 |
| 3rd UP Forecast | 1242.00 |
| 2nd UP Forecast | 1220.99 |
| 1st UP Forecast | 1199.98 |
| 1st DOWN Forecast | 1140.03 |
| 2nd DOWN Forecast | 1119.02 |
| 3rd DOWN Forecast | 1098.01 |
| 4th DOWN Forecast | 1064.02 |
KLBF Forecast2025
| 4th UP Forecast | 2355.11 |
| 3rd UP Forecast | 1975.04 |
| 2nd UP Forecast | 1740.11 |
| 1st UP Forecast | 1505.18 |
| 1st DOWN Forecast | 834.83 |
| 2nd DOWN Forecast | 599.9 |
| 3rd DOWN Forecast | 364.97 |
| 4th DOWN Forecast | -15.11 |
PT Kalbe Farma Tbk ( JK Indonesia Symbol : KLBF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KLBF Business Profile
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. It operates in four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. The company offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. It also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, pre-teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, the company operates Mitrasana Clinics, a health care service; contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products. Further, it offers health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as provides advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe Farma Tbk. is a subsidiary of PT Gira Sole Prima. Address: Gedung KALBE, Jakarta, Indonesia, 10510
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service